CYNO : Summary for Cynosure, Inc. - Yahoo Finance

U.S. Markets close in 3 hrs 15 mins

Cynosure, Inc. (CYNO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.350.00 (0.00%)
As of 12:45 PM EST. Market open.
People also watch:
CUTRELOSZLTQHURNCNMD
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close44.35
Open44.75
Bid44.25 x 400
Ask44.35 x 300
Day's Range44.25 - 45.20
52 Week Range32.90 - 55.94
Volume101,398
Avg. Volume337,731
Market Cap1.06B
Beta1.77
PE Ratio (TTM)50.11
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire4 hours ago

    Cynosure Recognized Among Deloitte's 2016 Technology Fast 500™

    WESTFORD, Mass., Dec. 5, 2016 /PRNewswire/ -- Cynosure, Inc. (CYNO) today announced it has been recognized as one of Deloitte's Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Cynosure received the award for its strong 121% revenue growth between the 2012 and 2015 fiscal years. "Cynosure is honored to be recognized as one of the fastest-growing companies in North America," said Michael Davin, the Company's president and CEO.

  • Cynosure (CYNO) Gets CFDA Approval to Market Icon System
    Zacks5 days ago

    Cynosure (CYNO) Gets CFDA Approval to Market Icon System

    Cynosure, Inc. (CYNO) announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the Icon Aesthetic System.

  • PR Newswire6 days ago

    Cynosure Receives CFDA Clearance to Market the Icon™ Aesthetic System in China

    WESTFORD, Mass., Nov. 29, 2016 /PRNewswire/ -- Cynosure, Inc. (CYNO) today announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the Icon™ Aesthetic System, the Company's next-generation platform technology for multiple aesthetic indications. With Icon, aesthetic practices in China will be able to deliver the industry's most popular energy-based treatments, including facial vessel and pigment clearance, wrinkle reduction, hair removal and scar and stretch mark treatment, in a single system. "Cynosure was the first U.S. aesthetic laser company to establish a wholly owned subsidiary in China more than 10 years ago, and we continue to expand our competitive position in that country – and the entire Asia Pacific (APAC) region – as part of our international growth strategy," said Michael Davin, the Company's president and CEO.